Remix Therapeutics Raises $70 Million in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Page 14 - Column Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Column Group Today - Breaking & Trending Today
Remix Therapeutics Closes $70 Million Series B Financing
/PRNewswire/ -- Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the...
Source: prnewswire.com
Remix Therapeutics Raises $70M in Series B Financing
The funding will be used to advance the company's RNA processing drug discovery platform REMaster, along with its therapeutic pipeline.
Source: precisiononcologynews.com
A2 Bio publishes key preclinical findings demonstrating potential of its highly selective Tmod™ cell therapy platform to revolutionize the treatment of solid tumors in select patients
/PRNewswire/ -- A2 Biotherapeutics, Inc. ("A2 Bio''), a biotechnology company focused on the treatment of solid tumors, announced today that key preclinical...
Source: prnewswire.com
A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell
AGOURA HILLS, Calif.--(BUSINESS WIRE)--#A2Bio--A2 Biotherapeutics, Inc. (“A2 Bio''), a biotechnology company focused on the treatment of solid tumors, announced today that key preclinical data related to its proprietary Tmod™ cell therapy platform have been published in Science Translational Medicine and Journal for...
Source: pharmiweb.com